225 related articles for article (PubMed ID: 28282989)
1. Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation.
Lu M; Xiong D; Sun W; Yu T; Hu Z; Ding J; Cai Y; Yang S; Pan B
Drug Deliv; 2017 Nov; 24(1):622-631. PubMed ID: 28282989
[TBL] [Abstract][Full Text] [Related]
2. A single subcutaneous administration of a sustained-release ivermectin suspension eliminates Psoroptes cuniculi infection in a rabbit farm.
Lu M; Cai Y; Yang S; Wan Q; Pan B
Drug Dev Ind Pharm; 2018 Dec; 44(12):2000-2004. PubMed ID: 30058406
[TBL] [Abstract][Full Text] [Related]
3. Failure of ivermectin efficacy against Psoroptes ovis infestation in cattle: Integrated pharmacokinetic-pharmacodynamic evaluation of two commercial formulations.
Lifschitz A; Fiel C; Steffan P; Cantón C; Muchiut S; Dominguez P; Lanusse C; Alvarez L
Vet Parasitol; 2018 Nov; 263():18-22. PubMed ID: 30389019
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of two ivermectin injectable formulations against psoroptic mange in feedlot cattle.
Genchi C; Alvinerie M; Forbes A; Bonfanti M; Genchi M; Vandoni S; Innocenti M; Sgoifo Rossi CA
Vet Parasitol; 2008 Nov; 158(1-2):110-6. PubMed ID: 18819751
[TBL] [Abstract][Full Text] [Related]
5. Treatment and control of bovine sarcoptic and psoroptic mange infestation with ivermectin long-acting injectable (IVOMEC(®) GOLD).
Hamel D; Joachim A; Löwenstein M; Pfister K; Silaghi C; Visser M; Winter R; Yoon S; Cramer L; Rehbein S
Parasitol Res; 2015 Feb; 114(2):535-42. PubMed ID: 25399813
[TBL] [Abstract][Full Text] [Related]
6. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
Sahoo J; Murthy PN; Biswal S; Manik
AAPS PharmSciTech; 2009; 10(1):27-33. PubMed ID: 19145487
[TBL] [Abstract][Full Text] [Related]
7. Plasma dispositions of ivermectin, doramectin and moxidectin following subcutaneous administration in rabbits.
Gokbulut C; Biligili A; Kart A; Turgut C
Lab Anim; 2010 Apr; 44(2):138-42. PubMed ID: 19959569
[TBL] [Abstract][Full Text] [Related]
8. Formulation Studies of Solid Self-Emulsifying Drug Delivery System of Ivermectin.
Patel VP; Lakkad HA; Ashara KC
Folia Med (Plovdiv); 2018 Dec; 60(4):580-593. PubMed ID: 31188767
[TBL] [Abstract][Full Text] [Related]
9. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
Huang BB; Liu DX; Liu K; Wu G
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779169
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen bond replacement--unearthing a novel molecular mechanism of surface solid dispersion for enhanced solubility of a drug for veterinary use.
Singh D; Pathak K
Int J Pharm; 2013 Jan; 441(1-2):99-110. PubMed ID: 23261857
[TBL] [Abstract][Full Text] [Related]
11. Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves.
Vercruysse J; Deprez P; Everaert D; Bassissi F; Alvinerie M
Vet Parasitol; 2008 Mar; 152(1-2):136-40. PubMed ID: 18207642
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin treatment of bovine psoroptic mange: effects on serum chemistry, hematology, organ weights, and leather quality.
Rehbein S; Visser M; Meyer M; Lindner T
Parasitol Res; 2016 Apr; 115(4):1519-28. PubMed ID: 26687969
[TBL] [Abstract][Full Text] [Related]
13. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
Dorati R; Genta I; Colzani B; Tripodo G; Conti B
Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
[TBL] [Abstract][Full Text] [Related]
14. Study of an injectable in situ forming gel for sustained-release of Ivermectin in vitro and in vivo.
Geng Z; Luo X; Zhang Z; Li H; Tian J; Yu Z
Int J Biol Macromol; 2016 Apr; 85():271-6. PubMed ID: 26708436
[TBL] [Abstract][Full Text] [Related]
15. A trial of doramectin injection and ivermectin spot-on for treatment of rabbits artificially infested with the ear mite "Psoroptes cuniculi".
Elhawary NM; Sorour SSGH; El-Abasy MA; Bazh EK; Sultan K
Pol J Vet Sci; 2017 Sep; 20(3):521-525. PubMed ID: 29166286
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneously injected ivermectin-loaded mixed micelles: formulation, pharmacokinetics and local irritation study.
Dong J; Song X; Lian X; Fu Y; Gong T
Drug Deliv; 2016 Sep; 23(7):2220-2227. PubMed ID: 25188004
[TBL] [Abstract][Full Text] [Related]
17. Psoroptes cuniculi induced oxidative imbalance in rabbits and its alleviation by using vitamins A, D3, E, and H as adjunctive remedial.
Singh SK; Dimri U; Sharma MC; Swarup D; Kumar M; Tiwary R
Trop Anim Health Prod; 2012 Jan; 44(1):43-8. PubMed ID: 21643667
[TBL] [Abstract][Full Text] [Related]
18. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization.
Camargo JA; Sapin A; Nouvel C; Daloz D; Leonard M; Bonneaux F; Six JL; Maincent P
Drug Dev Ind Pharm; 2013 Jan; 39(1):146-55. PubMed ID: 22397675
[TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of different ivermectin and doramectin formulations for mange control in grazing steers.
Canton C; Muchiut S; Dominguez MP; Lanusse C; Alvarez LI; Lifschitz A
Vet Parasitol; 2023 Apr; 316():109891. PubMed ID: 36780819
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis.
Ahmadpour E; Godrati-Azar Z; Spotin A; Norouzi R; Hamishehkar H; Nami S; Heydarian P; Rajabi S; Mohammadi M; Perez-Cordon G
Parasit Vectors; 2019 Oct; 12(1):469. PubMed ID: 31601244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
